Havana Cuba Business Travel Culture and Politics

Havana Cuba News

Cuba Culture News

Posted January 13, 2005 by publisher in Cuban Healthcare

Email this article | Print this article | Search Havana Journal        

Periodico26.com

Three new plants will begin producing the Cuban therapeutic vaccine against lung cancer to be used for clinical trials on the island and for similar efficiency tests in the United States.
In statements to Trabajadores weekly newspaper, Dr. Gisela Gonzalez, who heads the project at the Cuban Molecular Immunology Center, said two of the plants are being assembled at the Genetic Engineering and Biotechnology Research Center and the other one at the Immunology Center, where the final product will be made.
The plants are expected to be up and functioning during the first semester of the current year.
Gonzalez said the facilities will meet the requirements for the realization of experiments for new treatments in humans, included in the agreement signed in July 2004 by the Molecular Immunology Center and the American firm CANCERVAX, one of the most prestigious vaccine research companies in the world.
The development of vaccines and therapeutic monoclonal antibodies to treat malignant diseases is one of the most significant achievements of Cuban science.

  1. Follow up post #1 added on November 13, 2005 by Health-Effects.net wish to aquire vaccine with 2 total posts

    How do we at http://www.health-effects.net based in Panama get supplies of the Cancer Vaccine. We are especially interested in the Lung Cancer Vaccine.


Would you like to add more information?


Only members can add more information. Please register or log in

  • Advertise at Havana Journal Inc
Images of Cuba
Bicitaxi in Cuba
Follow Havana Journal
SUBSCRIBE to our Cuba Watch newsletter
LIKE us on Facebook

FOLLOW us on Twitter

CONNECT with us on Linked In

Section Archive
Havana Journal, Inc. BBB Business Review



Member of the Association for the Study of the Cuban Economy